MA

Matas A/SCSE Matas Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

0.706

Micro

Exchange

XCSE - Nasdaq Copenhagen A/S

MATAS.CO Stock Analysis

MA

Avoid

Based on Eyestock quantitative analysis, MATAS.CO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

34/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-51.1 %

Greatly overvalued

Market cap $B

0.706

Dividend yield

3.28 %

Shares outstanding

37.933 B

Matas A/S engages in the operation of retail chain for beauty, personal care, and health products. Each of the Company's stores offers products diversified into four product segments: Beauty Shop; Vital Shop; Material Shop, and Matas MediCare. The Beauty Shop segment includes cosmetics, fragrances, skincare and hair care products. The Vital Shop segment offers vitamins, minerals and supplements. The Material Shop segment encompasses household and personal care goods including cleaning and maintenance, personal grooming, childcare and sports-related products. The Matas MediCare segment offers over-the-counter medicine and first aid products. The firm's product offering includes both international and Danish health and beauty brands, as well as its own brands like Stripes (principal own brand), Matas Natur and Plaisir.

View Section: Eyestock Rating